Page
%P
-
Chapter
Immune Complex Therapies for Treatment of Immune Thrombocytopenia
Approximately 30% of patients with chronic immune thrombocytopenia (ITP), a common autoimmune disease, are refractory to standard therapies. In the last several years, several published reports have suggested ...
-
Chapter
Monoclonal Antibodies
Since the approval of rituximab in 1997 for the treatment of non-Hodgkin’s lymphoma, over 11 monoclonal antibodies (mAbs) have been approved for the treatment of cancer and hundreds are under development. Char...